Alpha Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,789
Closed -$2.29M 109
2022
Q1
$2.29M Buy
31,789
+11,231
+55% +$809K 0.5% 66
2021
Q4
$1.89M Buy
20,558
+452
+2% +$54K 0.42% 68
2021
Q3
$2.55M Sell
20,106
-1,475
-7% -$215K 0.6% 62
2021
Q2
$3.59M Buy
21,581
+8,878
+70% +$1.44M 0.84% 39
2021
Q1
$2.31M Buy
12,703
+780
+7% +$181K 0.59% 56
2020
Q4
$2.38M Buy
11,923
+356
+3% +$72.4K 0.6% 55
2020
Q3
$2.54M Buy
+11,567
New +$2.45M 0.73% 41

Other funds holding TDOC

Alpha Capital Management's TDOC Position: Q2 2022 in Review

Alpha Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 31,789 shares — an estimated $2.29M sold.

Alpha Capital Management first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $3.59M in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Alpha Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Alpha Capital Management sold 31,789 Teladoc Health shares in Q2 2022, an estimated $2.29M.
  • Alpha Capital Management first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
  • Alpha Capital Management's Teladoc Health position peaked at $3.59M in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Alpha Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.